NCT05255822View on ClinicalTrials.gov

INNA-051 Influenza Challenge Study

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

August 23, 2022

Study Completion Date

August 23, 2022

Conditions
Influenza Prophylaxis
Interventions
DRUG

INNA-051

Liquid for intra-nasal administration

OTHER

Placebo

Liquid for intra-nasal administration

Trial Locations (1)

Unknown

hVIVO, London

Sponsors
All Listed Sponsors
lead

ENA Respiratory Pty Ltd

INDUSTRY